Webinar

Feb 8, 2024 2:00 pm EST

Click HERE to register

 

DESCRIPTION

Ozempic and other GLP-1RA diabetes drugs are being used for simple weight loss. A very significant side effect, gastroparesis, is now being reported at an alarming rate. Learn about the current status of the litigation, case criteria, and the status of the JPMLs decision on where to send the MDL.